Professional
Added to YB: 2025-12-22
Pitch date: 2025-10-13
ICLR [neutral]
ICON Public Limited Company
-5.93%
current return
Author Info
No bio for this author
Company Info
ICON Public Limited Company, a clinical research organization, provides outsourced development and commercialization services in Ireland, rest of Europe, the United States, and internationally.
Market Cap
$13.7B
Pitch Price
$184.72
Price Target
N/A
Dividend
N/A
EV/EBITDA
10.73
P/E
24.00
EV/Sales
2.07
Sector
Life Sciences Tools and Services
Category
growth
Greenskeeper Asset Management Portfolio Holding: ICON Public Limited Company
ICLR (holding update): +20% contributor despite CRO industry headwinds from tariff/pricing fears causing pharma R&D cuts. Strong execution track record positions well for recovery as Trump admin agreements provide clarity, enabling recommitment to large-scale trials. Benefiting from trend toward larger, longer, globally diverse trials like GLP-1s.
Read full article (1 min)